Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1147-1154

  Debal, Vincent ^a   Breillout, Fabienne ^b   Manfait, Michel ^a  

^a UFR de Pharmacie   (France)

^b Centre d'Immunologie Pierre Fabre   (France)

Author keywords

Drug resistance; Microtubules; Navelbine; Phorbol esters; Retinoic acid; Taxoids; Vinca alkaloids

Indexed keywords

2 AMINOPURINE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BISINDOLYLMALEIMIDE; NAVELBINE; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; RETINOIC ACID; VIMENTIN; VINCA ALKALOID;

ARTICLE; BLADDER CARCINOMA; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOPLASM; CYTOSKELETON; DEPOLYMERIZATION; DESMOSOME; DRUG RESISTANCE; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; MICROTUBULE ASSEMBLY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINDLE CELL;

EID: 0030942928     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62: 385-427, 1993.
2. Ohta S, Nishio K, Kubo S, Nishio M, Ohmori T, Takahashi T and Saijo N: Characterisation of a vindesine-resistant human small-cell lung cancer cell line. Br J Cancer 68: 74-79, 1993.
3. Cabrai F and Barlow S: Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly. FASEB J 3: 1593-1599, 1989.
4. Debal V, Allam N, Morjani H, Millot JM, Braguer D, Breillout F and Manfait M: Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids. Br J Cancer 70: 1118-1125, 1994.
5. O'Toole C, Price ZH, Ohnuki Y and Unsgaard B: Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38: 64-76, 1978.
6. Pauwels O and Kiss R: Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca alkaloid, alkylating, and intercalating drugs. Cytometry 12: 388-397, 1991.
7. Debal V, Morjani H, Millot JM, Angihoust JF, Gourdier B and Manfait M: Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography. J Chromatogr 581: 93- 99, 1992.
8. Sullivan KF: Structure and utilization of tubulin isotypes. Ann Rev Cell Biol 4: 687-716, 1988.
9. Boyer B, Jouanneau J, Tucker G, Valles AM, Sastre X, Moens G and Thiery JP: La métastase cancéreuse. Médecine/sciences 6: 433-442, 1990.
10. Miettinen PJ, Ebner R, Lopez AR and Derynck R: TGF-ß induced transdifferentiation of mammary epithelial cells to mcsenchymal cells: involvement of type I receptors. J cell Biol 127: 2021-2036, 1994.
11. Shapiro SS and Dante JM: Modulation of glycosaminoglycan biosynthesis by retinoids. Ann NY Acad Sci 359: 306-321, 1981.
12. Amos B and Lotan R: Retinoid-sensitive cells and cell lines. Meth Enzymol 190: 217-225, 1990.
13. Kikkawa U, Kishimoto A and Nishizuka Y: The protein kinase C family: heterogeneity and its implications. Ann Rev Biochem 58: 3144, 1989.
14. Boiling J, Liminga G, Larsson R, Nygren P and Nilsson K: Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-KDa P-glycoprotein. Im J Cancer 58: 269-274, 1994.
15. Dumontet C, Duran GE, Steger KA, Beketic-Oreskovic L and Sikic BI: Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxcl (taxol). Cancer Res 56: 1091-1097, 1996.
16. Lieuvin A, Labbe JC, Doree M and Job D: Intrinsic microtubule stability in interphase cells. J Cell Biol 124: 985-996, 1994.
17. Gliksman NR, Parsons SF and Salmon ED: Okadaic acid induces interphase to mitotic-like microtubule dynamic instability by inactivating rescue. J Cell Biol 119: 1271-1276, 1992.
18. Gurland G and Gundersen GG: Protein phosphatase inhibitors induce the selective break down of stable microtubules in fibroblasts and epithelial cells. Proc Natl Acad Sci USA 90: 8827-8831, 1993.
19. Bershadsky AD and Gelfand VI: ATP-dependent regulation of cyloplasmic microtubule disassembly. Proc Natl Acad Sci USA 78: 3610-3613, 1981.
20. Boulikas T: DNA lesion-recognizing proteins and the p53 connection. Anticancer Res 16: 225-242, 1996.
21. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerba RL, Raskind WH and Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356, 1995.
22. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW and Galloway DA: Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis. Nature Med 2: 72-79, 1996.
23. Mukhopadhyay T and Roth JA: p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines. Anticancer Res 16: 105-112, 1996.